OneChain
OneChain is a spin-off company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop immunotherapies against hematological neoplasms using CAR-T candidates against different antigens.
B2X
Country
Email Address
Founded Date
2020
Founder
Headquarters
Latest Funding Round Date
June 22, 2023
Latest Funding Round Amount (USD)
7,365,308
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
10,955,005
Twitter URL
Official Website
Find more companies like OneChain
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.